PMID: 10112585Jun 8, 1991Paper

The costs of treating hypertension--an analysis of different cut-off points

Health Policy
M JohannessonL Råstam

Abstract

In this article the effects of different cut-off points for hypertension treatment are analysed, with respect to treatment costs. A theoretical blood pressure distribution is used to calculate the potential annual cost of treating all persons in Sweden above certain cut-off points for drug treatment. A lowering of the cut-off point from 105 mm Hg to 100 mm Hg diastolic blood pressure could potentially lead to an increase in annual costs of approximately 80m pounds. Further lowering from 100 to 95 mm Hg in turn could increase annual costs by about 110m pounds. The potential annual cost of treating all persons (roughly 1.6 million) with a diastolic blood pressure of greater than or equal to 95 mm Hg with drugs is calculated as being roughly 40 pounds per inhabitant in Sweden. The Swedish cut-off point for treatment (95 mm Hg) can be expected to lead to roughly 50 per cent higher treatment costs than the British cut-off point (100 mm Hg).

References

Jun 1, 1990·Journal of Epidemiology and Community Health·P R Croft, J K Cruickshank
Oct 1, 1989·Cardiovascular Drugs and Therapy·J R Hampton
Jan 1, 1989·Clinical and Experimental Hypertension. Part A, Theory and Practice
Sep 4, 1987·JAMA : the Journal of the American Medical Association·W B KannelR B D'Agostino
Dec 25, 1987·JAMA : the Journal of the American Medical Association·B SchuckerB M Rifkind
Nov 1, 1993·Scandinavian Journal of Clinical and Laboratory Investigation·M JohannessonL Lindholm
Dec 10, 1988·International Journal of Technology Assessment in Health Care·J Persson, L Borquist

❮ Previous
Next ❯

Citations

Jan 1, 1992·International Journal of Technology Assessment in Health Care·M Johannesson
Nov 8, 2002·Journal of Evaluation in Clinical Practice·Reginald P SequeiraVijay S Mathur
Oct 1, 1991·Journal of Internal Medicine·M JohannessonB Jönsson
Mar 11, 2000·Drugs·H PardellR Hernández del Rey
May 11, 1991·Lancet·L Råstam, G Sjönell
Jul 12, 2012·International Journal of Geriatric Psychiatry·C LindholmA Wimo
Nov 21, 2014·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Kristin Kahle-WrobleskiMark Belger
Jan 29, 2016·Journal of Aging and Health·Örjan ÅkerborgMats Rosenlund
Jan 7, 2009·Therapeutic Advances in Cardiovascular Disease·Luis Alcocer, Liliana Cueto
Jun 13, 2018·International Journal of Geriatric Psychiatry·Takayo NakabeYuichi Imanaka
Nov 8, 2018·Journal of Alzheimer's Disease : JAD·Niels JanssenUNKNOWN Consortium Actifcare
Oct 30, 2018·Journal of Alzheimer's Disease : JAD·Ron L H HandelsUNKNOWN Actifcare consortium
Aug 9, 2019·PloS One·C VossiusA M M Rokstad
May 18, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Anders GustavssonLinus Jönsson
Feb 6, 2020·International Journal of Geriatric Psychiatry·Sophie VandepitteLieven Annemans
Sep 13, 2019·PloS One·Martina LundqvistLars-Åke Levin
Jun 10, 2020·Neurology·Georgina M ChambersMichelle A Farrar
Aug 31, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Evelyn Serreyn LundinPreben Kjölhede
Jun 24, 2017·Brain and Behavior·Josefine PerssonGunilla Forsberg-Wärleby
Jul 27, 2017·Health and Quality of Life Outcomes·Josefine PerssonGunilla Forsberg-Wärleby
Dec 13, 2019·Scandinavian Journal of Public Health·Jenny AlwinNiklas Ekerstad
Dec 18, 2016·Alzheimer's Research & Therapy·Anders WimoLennarth Johansson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.